William S Shanahan - Net Worth and Insider Trading

William S Shanahan Net Worth

The estimated net worth of William S Shanahan is at least $44 Million dollars as of 2024-04-25. William S Shanahan is the Director of Visa Inc and owns about 161,224 shares of Visa Inc (V) stock worth over $44 Million. William S Shanahan is also the Director of Cyclo Therapeutics Inc and owns about 36,677 shares of Cyclo Therapeutics Inc (CYTH) stock worth over $47,680. Details can be seen in William S Shanahan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that William S Shanahan has not made any transactions after 2020-04-24 and currently still holds the listed stock(s).

Transaction Summary of William S Shanahan

To

William S Shanahan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, William S Shanahan owns 3 companies in total, including Cyclo Therapeutics Inc () , Visa Inc () , and Colgate-Palmolive Co () .

Click here to see the complete history of William S Shanahan’s form 4 insider trades.

Insider Ownership Summary of William S Shanahan

Ticker Comapny Transaction Date Type of Owner
Cyclo Therapeutics Inc 2020-04-24 director
Visa Inc 2012-05-24 director
Colgate-Palmolive Co 2003-09-11 President

William S Shanahan Latest Holdings Summary

William S Shanahan currently owns a total of 2 stocks. Among these stocks, William S Shanahan owns 161,224 shares of Visa Inc (V) as of May 24, 2012, with a value of $44 Million and a weighting of 99.89%. William S Shanahan also owns 36,677 shares of Cyclo Therapeutics Inc (CYTH) as of April 24, 2020, with a value of $47,680 and a weighting of 0.11%.

Latest Holdings of William S Shanahan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
V Visa Inc 2012-05-24 161,224 275.02 44,339,824
CYTH Cyclo Therapeutics Inc 2020-04-24 36,677 1.30 47,680

Holding Weightings of William S Shanahan


William S Shanahan Form 4 Trading Tracker

According to the SEC Form 4 filings, William S Shanahan has made a total of 0 transactions in Visa Inc (V) over the past 5 years. The most-recent trade in Visa Inc is the sale of 108,000 shares on May 24, 2012, which brought William S Shanahan around $3 Million.

According to the SEC Form 4 filings, William S Shanahan has made a total of 5 transactions in Cyclo Therapeutics Inc (CYTH) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Cyclo Therapeutics Inc is the acquisition of 10,000 shares on April 24, 2020, which cost William S Shanahan around $100,000.

Insider Trading History of William S Shanahan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

William S Shanahan Trading Performance

GuruFocus tracks the stock performance after each of William S Shanahan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William S Shanahan is 31.07%. GuruFocus also compares William S Shanahan's trading performance to market benchmark return within the same time period. The performance of stocks bought by William S Shanahan within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how William S Shanahan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of William S Shanahan

Average Return

-17.67%

Average return per transaction

Outperforming Transactions

20%

1 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.01 31.07 -26.71 -17.67 -40.86 -53.86
Relative Return to S&P 500(%) 4.58 23.95 -23.76 -37.09 -63.21 -64.57

William S Shanahan Ownership Network

Ownership Network List of William S Shanahan

No Data

Ownership Network Relation of William S Shanahan


William S Shanahan Owned Company Details

What does Cyclo Therapeutics Inc do?

Who are the key executives at Cyclo Therapeutics Inc?

William S Shanahan is the director of Cyclo Therapeutics Inc. Other key executives at Cyclo Therapeutics Inc include 10 percent owner Rafael Holdings, Inc. , director & Chief Executive Officer Jeffrey Tate , and SVP for Medical Affairs Sharon Hemond Hrynkow .

Cyclo Therapeutics Inc () Insider Trades Summary

Over the past 18 months, William S Shanahan made no insider transaction in Cyclo Therapeutics Inc (). Other recent insider transactions involving Cyclo Therapeutics Inc () include a net purchase of 4,000,000 shares made by Rafael Holdings, Inc. , a net purchase of 299,402 shares made by N Scott Fine , and a net purchase of 59,881 shares made by Markus Sieger .

In summary, during the past 3 months, insiders sold 0 shares of Cyclo Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclo Therapeutics Inc () were sold and 4,449,105 shares were bought by its insiders, resulting in a net purchase of 4,449,105 shares.

Cyclo Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cyclo Therapeutics Inc Insider Transactions

No Available Data

William S Shanahan Mailing Address

Above is the net worth, insider trading, and ownership report for William S Shanahan. You might contact William S Shanahan via mailing address: C/o Visa Inc., 123 Mission Street, San Francisco Ca 94104.

Discussions on William S Shanahan

No discussions yet.